The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - GlaxoSmithKline; MSD/Merck
Research Funding - AstraZeneca/MedImmune (Inst); GlaxoSmithKline (Inst); MSD (Inst)
Expert Testimony - GlaxoSmithKline; MSD
Role of cytoreductive surgery for the second ovarian cancer relapse in patients previously treated with chemotherapy alone at first relapse: A subanalysis of the DESKTOP III trial.
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Christina Fotopoulou
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Global Oncology One; Roche/Genentech
Research Funding - Myrovlytis Trust
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akesobio - China; Amgen (Inst); AstraZeneca; Britol Myers Squibb; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Eisai; Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; Millennium (Inst); MSD; Novartis; Novocure; Octimet (Inst); Oncoinvent; Roche; Seagen; Sotio; Verastem (Inst); Zentalis
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Alexander Reuss
No Relationships to Disclose
 
Gwenael Ferron
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Olympus; Rand Biotech
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche Pharma AG
 
Werner Meier
Honoraria - AstraZeneca/MedImmune; GlaxoSmithKline
 
Stefano Greggi
Consulting or Advisory Role - AstraZeneca/MedImmune; Roche
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Roche
 
Berit J. Mosgaard
No Relationships to Disclose
 
Frederic Selle
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; MSD; Sandoz
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Speakers' Bureau - AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro; MSD; Roche
 
Frederic Guyon
No Relationships to Disclose
 
Christophe Pomel
Honoraria - MSD; Pfizer
Consulting or Advisory Role - Pfizer
 
Fabrice Lecuru
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline
 
Rongyu Zang
No Relationships to Disclose
 
Kristina Hellmann
No Relationships to Disclose
 
Jae-Weon Kim
No Relationships to Disclose
 
Margarita Romeo
No Relationships to Disclose
 
Francesco Raspagliesi
No Relationships to Disclose
 
Brynhildur Eyjólfsdóttir
Other Relationship - Intuitive Surgical (Inst)
 
Andreas Du Bois
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; Ingress Health; Mersana; Roche/Genentech; Zodiac Pharma
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)